News & Updates

Amlodipine trumps lisinopril, chlorthalidone in lowering gout risk

18 Apr 2020

Amlodipine is more effective than lisinopril or chlorthalidone in reducing the long-term risk of gout in older adults with hypertension, according to the ALLHAT* study.

Amlodipine trumps lisinopril, chlorthalidone in lowering gout risk

18 Apr 2020

Tofacitinib an effective painkiller in rheumatic musculoskeletal diseases

17 Apr 2020 by

The oral Janus kinase inhibitor tofacitinib provides rapid and sustained pain relief across several inflammatory rheumatic musculoskeletal diseases, namely rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, according to a posthoc analysis of randomized controlled trials.

Tofacitinib an effective painkiller in rheumatic musculoskeletal diseases

17 Apr 2020

Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients

16 Apr 2020

Immunosuppressive treatment with cyclophosphamide and rituximab in elderly patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) is not associated with hospitalization and may result in the development of less permanent organ damage, reveals a study.

Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients

16 Apr 2020

Adding an old gout drug to standard therapy cost-effective post-MI

13 Apr 2020 by

A gout drug that’s been around for years reduced the risk of ischaemic cardiovascular (CV) events when given at a low dose in patients who had myocardial infarction (MI) and was cost-effective, an analysis of the COLCOT* trial has shown.

Adding an old gout drug to standard therapy cost-effective post-MI

13 Apr 2020

Ambrisentan–tadalafil combo effective against connective tissue disease-related PAH

10 Apr 2020

Combination therapy with ambrisentan plus tadalafil provides greater benefits than either agent alone in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH), especially those with typical PAH haemodynamic characteristics at baseline, according to a posthoc analysis of the AMBITION* study.

Ambrisentan–tadalafil combo effective against connective tissue disease-related PAH

10 Apr 2020

Auto-injector device effective for self-administration of certolizumab pegol

07 Apr 2020 by

A new reusable auto-injector e-device allows for the safe and effective self-injection of certolizumab pegol (CZP), according to a new study.

Auto-injector device effective for self-administration of certolizumab pegol

07 Apr 2020

Mindfulness promotes better sleep in fibromyalgia patients

04 Apr 2020

Among patients with fibromyalgia, practicing mindfulness may alleviate pain, depression and anxiety, thereby conferring benefits for sleep, a study has found.

Mindfulness promotes better sleep in fibromyalgia patients

04 Apr 2020

CD40 blockade shows therapeutic potential in Sjögren's syndrome

02 Apr 2020

The novel anti-CD40 monoclonal antibody iscalimab has demonstrated clinical activity in patients with primary Sjögren's syndrome in a proof-of-concept study.

CD40 blockade shows therapeutic potential in Sjögren's syndrome

02 Apr 2020

Comorbidity type affects quality of life in PsA patients

02 Apr 2020

The type of comorbidity, rather than its number, appears to have a greater impact on the quality of life (QoL) of patients with psoriatic arthritis (PsA), a recent study has found.

Comorbidity type affects quality of life in PsA patients

02 Apr 2020

Steroid for hand OA: A potential short-term treatment option?

01 Apr 2020 by

Short-term treatment (6 weeks) with 10 mg prednisolone effectively reduces finger pain and improves function in patients who have painful hand osteoarthritis (OA) coupled with signs of inflammation, the HOPE* study has shown.

Steroid for hand OA: A potential short-term treatment option?

01 Apr 2020

News & Updates

Filter by Specialty:

Specialty:

Amlodipine trumps lisinopril, chlorthalidone in lowering gout risk

Amlodipine trumps lisinopril, chlorthalidone in lowering gout risk

Tofacitinib an effective painkiller in rheumatic musculoskeletal diseases

Tofacitinib an effective painkiller in rheumatic musculoskeletal diseases

Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients

Cyclophosphamide, rituximab tied to less permanent organ damage in older polyangiitis patients

Adding an old gout drug to standard therapy cost-effective post-MI

Adding an old gout drug to standard therapy cost-effective post-MI

Ambrisentan–tadalafil combo effective against connective tissue disease-related PAH

Ambrisentan–tadalafil combo effective against connective tissue disease-related PAH

Auto-injector device effective for self-administration of certolizumab pegol

Auto-injector device effective for self-administration of certolizumab pegol

Mindfulness promotes better sleep in fibromyalgia patients

Mindfulness promotes better sleep in fibromyalgia patients

CD40 blockade shows therapeutic potential in Sjögren's syndrome

CD40 blockade shows therapeutic potential in Sjögren's syndrome

Comorbidity type affects quality of life in PsA patients

Comorbidity type affects quality of life in PsA patients

Steroid for hand OA: A potential short-term treatment option?

Steroid for hand OA: A potential short-term treatment option?